Didier Lebrec

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Physiology

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Rautou Pierre-Emmanuel; Moucari Rami; Cazals-Hatem Dominique; Escolano Sylvie; Denié Cécile; Douarin Ludivine; Francoz Claire; Durand François; Ozenne Violaine; Imbert Audrey; Moreau Richard; Lebrec Didier; Plessier Aurélie; Valla Dominique
Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome.
Lebrec D; Moreau R
[Progress in portal hypertension]
Tazi Khalid A; Quioc Jean-Jacques; Abdel-Razek Wael; Tellier Zéra; Guichard Cécile; Ogier-Denis Eric; Lebrec Didier; Moreau Richard
Protein array technology to investigate cytokine production by monocytes from patients with advanced alcoholic cirrhosis: An ex vivo pilot study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Didier Lebrec (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Rautou Pierre-Emmanuel; Moucari Rami; Cazals-Hatem Dominique; Escolano Sylvie; Denié Cécile; Douarin Ludivine; Francoz Claire; Durand François; Ozenne Violaine; Imbert Audrey; Moreau Richard; Lebrec Didier; Plessier Aurélie; Valla Dominique
Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(11):1230-5.
2009: Lebrec D; Moreau R
[Progress in portal hypertension]
Gastroentérologie clinique et biologique 2009;33(8-9):799-810.
2009: Tazi Khalid A; Quioc Jean-Jacques; Abdel-Razek Wael; Tellier Zéra; Guichard Cécile; Ogier-Denis Eric; Lebrec Didier; Moreau Richard
Protein array technology to investigate cytokine production by monocytes from patients with advanced alcoholic cirrhosis: An ex vivo pilot study.
Hepatology research : the official journal of the Japan Society of Hepatology 2009;39(7):706-15.
2009: Mohammadi Morvarid Shir; Thabut Dominique; Cazals-Hatem Dominique; Galbois Arnaud; Rudler Marika; Bonnefont-Rousselot Dominique; Moreau Richard; Lebrec Didier; Tazi Khalid A
Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats.
Liver international : official journal of the International Association for the Study of the Liver 2009;29(5):692-700.
2009: Galbois Arnaud; Thabut Dominique; Tazi Khalid A; Rudler Marika; Mohammadi Morvarid Shir; Bonnefont-Rousselot Dominique; Bennani Hind; Bezeaud Annie; Tellier Zera; Guichard Cécile; Coant Nicolas; Ogier-Denis Eric; Moreau Richard; Lebrec Didier
Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis.
Hepatology (Baltimore, Md.) 2009;49(1):175-84.
2008: Rautou Pierre-Emmanuel; Cazals-Hatem Dominique; Moreau Richard; Francoz Claire; Feldmann Gérard; Lebrec Didier; Ogier-Denis Eric; Bedossa Pierre; Valla Dominique; Durand François
Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy.
Gastroenterology 2008;135(3):840-8, 848.e1-3.
2008: Le Pavec Jérôme; Souza Rogério; Herve Philippe; Lebrec Didier; Savale Laurent; Tcherakian Colas; Jaïs Xavier; Yaïci Azzedine; Humbert Marc; Simonneau Gérald; Sitbon Olivier
Portopulmonary hypertension: survival and prognostic factors.
American journal of respiratory and critical care medicine 2008;178(6):637-43.
2008: Moreau R; Lebrec D
[Pathophysiology and prognosis of refractory ascites in patients with cirrhosis]
Gastroentérologie clinique et biologique 2008;32(8-9):705-9.
2008: Moreau R; Durand F; Lebrec D
[Refractory ascites in patients with cirrhosis]
Gastroentérologie clinique et biologique 2008;32(8-9):703-4.
2008: Moreau R; Lebrec D
[Management of refractory ascites with the exception of the transjugular intrahepatic portosystemic shunt (TIPS) and liver transplantation]
Gastroentérologie clinique et biologique 2008;32(8-9):710-6.
2008: Lebrec D; Moreau R
[Management of refractory ascites by the transjugular intrahepatic portosystemic shunt (TIPS)]
Gastroentérologie clinique et biologique 2008;32(8-9):717-20.
2008: Thabut Dominique; Moreau Richard; Lebrec Didier
Screening for esophageal varices: Endoscopy, other tools, or endoscopy and other tools?
Hepatology (Baltimore, Md.) 2008;47(5):1434-6.
2008: Bosch Jaime; Thabut Dominique; Albillos Agustín; Carbonell Nicolas; Spicak Julius; Massard Julien; D'Amico Gennaro; Lebrec Didier; de Franchis Roberto; Fabricius Søren; Cai Yan; Bendtsen Flemming;
Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.
Hepatology (Baltimore, Md.) 2008;47(5):1604-14.
2008: Sersté T; Lebrec D; Valla D; Moreau R
Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascites.
Acta gastro-enterologica Belgica 2008;71(1):9-14.
2008: Moreau Richard; Lebrec Didier
Acute kidney injury: new concepts. Hepatorenal syndrome: the role of vasopressors.
Nephron. Physiology 2008;109(4):p73-9.
2007: Malyshev Eugene; Tazi Khalid A; Moreau Richard; Lebrec Didier
Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats.
Journal of gastroenterology and hepatology 2007;22(12):2195-201.
2007: Thabut Dominique; Massard Julien; Gangloff Alice; Carbonell Nicolas; Francoz Claire; Nguyen-Khac Eric; Duhamel Christian; Lebrec Didier; Poynard Thierry; Moreau Richard
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure.
Hepatology (Baltimore, Md.) 2007;46(6):1872-82.
2007: Thabut Dominique; Tazi Khalid A; Bonnefont-Rousselot Dominique; Aller Maria; Farges Olivier; Guimont Marie-Christine; Tellier Zera; Guichard Cecile; Ogier-Denis Eric; Poynard Thierry; Moreau Richard; Lebrec Didier
High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats.
Hepatology (Baltimore, Md.) 2007;46(6):1893-906.
2007: Thabut D; Imbert-Bismut F; Cazals-Hatem D; Messous D; Muntenau M; Valla D C; Moreau R; Poynard T; Lebrec D
Relationship between the Fibrotest and portal hypertension in patients with liver disease.
Alimentary pharmacology & therapeutics 2007;26(3):359-68.
2007: Tazi Khalid A; Bièche Ivan; Paradis Valérie; Guichard Cécile; Laurendeau Ingrid; Dargère Delphine; Legrand Agnès; Fay Michèle; Pedruzzi Eric; Robin Marie-Anne; Cazals-Hatem Dominique; Tellier Zéra; Bernuau Dominique; Feldmann Gérard; Vidaud Michel; Lebrec Didier; Ogier-Denis Eric; Moreau Richard
In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats.
Journal of hepatology 2007;46(6):1075-88.
2007: Poynard Thierry; Morra Rachel; Halfon Philippe; Castera Laurent; Ratziu Vlad; Imbert-Bismut Françoise; Naveau Sylvie; Thabut Dominique; Lebrec Didier; Zoulim Fabien; Bourliere Marc; Cacoub Patrice; Messous Djamila; Munteanu Mona; de Ledinghen Victor
Meta-analyses of FibroTest diagnostic value in chronic liver disease.
BMC gastroenterology 2007;7():40.
2007: Reichen Jürg; Lebrec Didier
The future treatment of portal hypertension.
Best practice & research. Clinical gastroenterology 2007;21(1):191-202.
2007: Moreau Richard; Lebrec Didier
Diagnosis and treatment of acute renal failure in patients with cirrhosis.
Best practice & research. Clinical gastroenterology 2007;21(1):111-23.
2006: Sersté Thomas; Bourgeois Nadine; Lebrec Didier; Evrard Sylvie; Devière Jacques; Le Moine Olivier
Relationship between the degree of portal hypertension and the onset of spontaneous bacterial peritonitis in patients with cirrhosis.
Acta gastro-enterologica Belgica 2006;69(4):355-60.
2006: Moreau Richard; Lebrec Didier
Molecular and structural basis of portal hypertension.
Clinics in liver disease 2006;10(3):445-57, vii.
2006: Tazi Khalid A; Quioc Jean-Jacques; Saada Véronique; Bezeaud Annie; Lebrec Didier; Moreau Richard
Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M.
Journal of hepatology 2006;45(2):280-9.
2006: Quioc Jean-Jacques; Tazi Khalid A; Lebrec Didier; Moreau Richard
The quest for new therapies in patients with cirrhosis and sepsis. Time to move from the lab to the bedside.
Gastroentérologie clinique et biologique 2006;30(6-7):819-22.
2006: Thabut Dominique; Naveau Sylvie; Charlotte Frederic; Massard Julien; Ratziu Vlad; Imbert-Bismut Françoise; Cazals-Hatem Dominique; Abella Annie; Messous Djamila; Beuzen Fabienne; Munteanu Mona; Taieb Julien; Moreau Richard; Lebrec Didier; Poynard Thierry
The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease.
Journal of hepatology 2006;44(6):1175-85.
2006: Deltenre Pierre; Lebrec Didier; Mathurin Philippe
Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites.
Gastroenterology 2006;130(4):1372-3; author reply 1373.
2006: Moreau Richard; Lebrec Didier
The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.
Hepatology (Baltimore, Md.) 2006;43(3):385-94.
2006: Moreau Richard; Valla Dominique-Charles; Durand-Zaleski Isabelle; Bronowicki Jean-Pierre; Durand François; Chaput Jean-Claude; Dadamessi Innocenti; Silvain Christine; Bonny Corinne; Oberti Frédéric; Gournay Jérôme; Lebrec Didier; Grouin Jean-Marie; Guémas Eric; Golly Dominique; Padrazzi Bruno; Tellier Zéra
Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(1):46-54.
2006: Provencher Steeve; Herve Philippe; Jais Xavier; Lebrec Didier; Humbert Marc; Simonneau Gerald; Sitbon Olivier
Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension.
Gastroenterology 2006;130(1):120-6.
2005: Lebrec Didier; Moreau Richard
[Are the diagnosis and measurement of portal hypertension of interest?]
Gastroentérologie clinique et biologique 2005;29(10):967-8.
2005: Sztrymf Benjamin; Libert Jean-Marie; Mougeot Christine; Lebrec Didier; Mazmanian Michel; Humbert Marc; Herve Philippe
Cirrhotic rats with bacterial translocation have higher incidence and severity of hepatopulmonary syndrome.
Journal of gastroenterology and hepatology 2005;20(10):1538-44.
2005: Tazi Khalid A; Moreau Richard; Hervé Philippe; Dauvergne Agnes; Cazals-Hatem Dominique; Bert Frederic; Poirel Odile; Rabiller Anne; Lebrec Didier
Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling.
Gastroenterology 2005;129(1):303-14.
2005: Ahloulay Mina; Bankir Lise; Lugnier Claire; Le Bec Alain; Poirel Odile; Moreau Richard; Lebrec Didier
Cyclic AMP-phosphodiesterases inhibitor improves sodium excretion in rats with cirrhosis and ascites.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(2):403-9.
2005: Deltenre P; Mathurin P; Dharancy S; Moreau R; Bulois P; Henrion J; Pruvot F R; Ernst O; Paris J C; Lebrec D
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(2):349-56.
2005: Lebrec Didier; Vinel Jean-Pierre; Dupas Jean-Louis
Complications of portal hypertension in adults: a French consensus.
European journal of gastroenterology & hepatology 2005;17(4):403-10.
2004: Urbanowicz W; Sogni P; Moreau R; Tazi K A; Barriere E; Poirel O; Martin A; Guimont M C; Cazals-Hatem D; Lebrec D
Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats.
Gut 2004;53(12):1844-9.
2004: Moreau Richard; Delègue Paul; Pessione Fabienne; Hillaire Sophie; Durand François; Lebrec Didier; Valla Dominique-Charles
Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
Liver international : official journal of the International Association for the Study of the Liver 2004;24(5):457-64.
2004: Lebrec D
Review article: future indications for terlipressin therapy.
Alimentary pharmacology & therapeutics 2004;20 Suppl 3():65-7; discussion 68.
2004: Moreau R; Lebrec D
Review article: hepatorenal syndrome--definitions and diagnosis.
Alimentary pharmacology & therapeutics 2004;20 Suppl 3():24-8; discussion 29-30.
2004: Simonneau Gerald; Galiè Nazzareno; Rubin Lewis J; Langleben David; Seeger Werner; Domenighetti Guido; Gibbs Simon; Lebrec Didier; Speich Rudolf; Beghetti Maurice; Rich Stuart; Fishman Alfred
Clinical classification of pulmonary hypertension.
Journal of the American College of Cardiology 2004;43(12 Suppl S):5S-12S.
2004: Sztrymf B; Rabiller A; Nunes H; Savale L; Lebrec D; Le Pape A; de Montpreville V; Mazmanian M; Humbert M; Hervé P
Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2004;23(5):752-8.
2003: Plessier Aurélie; Denninger Marie-Hélène; Consigny Yann; Pessione Fabienne; Francoz Claire; Durand François; Francque Sven; Bezeaud Annie; Chauvelot-Moachon Laurence; Lebrec Didier; Valla Dominique-Charles; Moreau Richard
Coagulation disorders in patients with cirrhosis and severe sepsis.
Liver international : official journal of the International Association for the Study of the Liver 2003;23(6):440-8.
2003: Langlet Philippe; Escolano Sylvie; Valla Dominique; Coste-Zeitoun Delphine; Denie Cecile; Mallet Alain; Levy Victor-Georges; Franco Dominique; Vinel Jean-Pierre; Belghiti Jacques; Lebrec Didier; Hay Jean-Marie; Zeitoun Guy
Clinicopathological forms and prognostic index in Budd-Chiari syndrome.
Journal of hepatology 2003;39(4):496-501.
2003: Colle Isabelle O; Moreau Richard; Godinho Erica; Belghiti Jacques; Ettori Florence; Cohen-Solal Alain; Mal Hervé; Bernuau Jacques; Marty Jean; Lebrec Didier; Valla Dominique; Durand François
Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study.
Hepatology (Baltimore, Md.) 2003;37(2):401-9.
2003: Myers Robert P; Cerini Raimondo; Sayegh Raymond; Moreau Richard; Degott Claude; Lebrec Didier; Lee Samuel S
Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations.
Hepatology (Baltimore, Md.) 2003;37(2):393-400.
2003: Moreau Richard; Lebrec Didier
Acute renal failure in patients with cirrhosis: perspectives in the age of MELD.
Hepatology (Baltimore, Md.) 2003;37(2):233-43.
2002: Valla Dominique-Charles; Condat Bertrand; Lebrec Didier
Spectrum of portal vein thrombosis in the West.
Journal of gastroenterology and hepatology 2002;17 Suppl 3():S224-7.
2002: Moreau Richard; Barrière Eric; Tazi Khalid A; Lardeux Bernard; Dargère Delphine; Urbanowicz Waldemar; Poirel Odile; Chauvelot-Moachon Laurence; Guimont Marie-Christine; Bernuau Dominique; Lebrec Didier
Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis.
Hepatology (Baltimore, Md.) 2002;36(5):1070-8.
2002: Colle Isabelle; Langlet Philippe; Barrière Eric; Heller Jörg; Rassiat Emmanuel; Condat Bertrand; Carayon Alain; Valla Dominique; Moreau Richard; Lebrec Didier
Evolution of hypoxemia in patients with severe cirrhosis.
Journal of gastroenterology and hepatology 2002;17(10):1106-9.
2002: Rabiller Anne; Nunes Hilario; Lebrec Didier; Tazi Khalid A; Wartski Myriam; Dulmet Elisabeth; Libert Jean-Marie; Mougeot Christine; Moreau Richard; Mazmanian Michel; Humbert Marc; Hervé Philippe
Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome.
American journal of respiratory and critical care medicine 2002;166(4):514-7.
2002: Colle Isabelle; Durand François; Pessione Fabienne; Rassiat Emmanuel; Bernuau Jacques; Barrière Eric; Lebrec Didier; Valla Dominique-Charles; Moreau Richard
Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.
Journal of gastroenterology and hepatology 2002;17(8):882-8.
2002: Hillaire S; Bonte E; Denninger M-H; Casadevall N; Cadranel J-F; Lebrec D; Valla D; Degott C
Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients.
Gut 2002;51(2):275-80.
2002: Tazi Khalid A; Barrière Eric; Moreau Richard; Heller Jörg; Sogni Philippe; Pateron Dominique; Poirel Odile; Lebrec Didier
Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis.
Gastroenterology 2002;122(7):1869-77.
2002: Deltenre Pierre; Rufat Pierre; Hillaire Sophie; Elman Annie; Moreau Richard; Valla Dominique; Lebrec Didier
Lack of prognostic usefulness of hepatic venous pressures and hemodynamic values in a select group of patients with severe alcoholic cirrhosis.
The American journal of gastroenterology 2002;97(5):1187-90.
2002: Tazi Khalid A; Barrière Eric; Moreau Richard; Poirel Odile; Lebrec Didier
Relationship between protein kinase C alterations and nitric oxide overproduction in cirrhotic rat aortas.
Liver 2002;22(2):178-83.
2002: Rassiat Emmanuel; Barrière Eric; Durand Francois; Bernuau Jacques; Belghiti Jacques; Valla Dominique; Moreau Richard; Lebrec Didier
Pulmonary hemodynamics and gas exchange after liver transplantation in patients with cirrhosis.
Digestive diseases and sciences 2002;47(4):746-9.
2002: Lebrec Didier
[Angiotensin II receptor antagonists and portal hypertension]
Gastroentérologie clinique et biologique 2002;26(3):254-5.
2002: Moreau R; Asselah T; Condat B; de Kerguenec C; Pessione F; Bernard B; Poynard T; Binn M; Grangé J D; Valla D; Lebrec D
Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.
Gut 2002;50(1):90-4.
2001: Lebrec D
Life, death, and varices.
Gut 2001;49(5):607-8.
2001: Barrière E; Tazi K A; Pessione F; Heller J; Poirel O; Lebrec D; Moreau R
Role of small-conductance Ca2+-dependent K+ channels in in vitro nitric oxide-mediated aortic hyporeactivity to alpha-adrenergic vasoconstriction in rats with cirrhosis.
Journal of hepatology 2001;35(3):350-7.
2001: Nunes H; Lebrec D; Mazmanian M; Capron F; Heller J; Tazi K A; Zerbib E; Dulmet E; Moreau R; Dinh-Xuan A T; Simonneau G; Hervé P
Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats.
American journal of respiratory and critical care medicine 2001;164(5):879-85.
2001: Lebrec D
Drug therapy for portal hypertension.
Gut 2001;49(3):441-2.
2001: Lebrec D; Moreau R
Pathogenesis of portal hypertension.
European journal of gastroenterology & hepatology 2001;13(4):309-11.
2001: Moreau R; Chagneau C; Heller J; Chevenne D; Langlet P; Deltenre P; Hillaire S; Lefilliatre P; Pateron D; Sogni P; Valla D; Lebrec D
Hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose.
Scandinavian journal of gastroenterology 2001;36(3):303-8.
2001: Colle I; Moreau R; Pessione F; Rassiat E; Heller J; Chagneau C; Pateron D; Barrière E; Condat B; Sogni P; Valla D; Lebrec D
Relationships between haemodynamic alterations and the development of ascites or refractory ascites in patients with cirrhosis.
European journal of gastroenterology & hepatology 2001;13(3):251-6.
2001: Lefilliatre P; Sogni P; Bertrand V; Del Soldato P; Pateron D; Moreau R; Lebrec D
Aortic hyporeactivity to norepinephrine induced by lipopolysaccharide in cirrhotic rats: beneficial effects of a non-steroidal anti-inflammatory drug coupled with a nitric oxide donor.
Journal of gastroenterology and hepatology 2001;16(1):70-8.
2000: Barriere E; Tazi K A; Rona J P; Pessione F; Heller J; Lebrec D; Moreau R
Evidence for an endothelium-derived hyperpolarizing factor in the superior mesenteric artery from rats with cirrhosis.
Hepatology (Baltimore, Md.) 2000;32(5):935-41.
2000: Heller J; Sogni P; Barrière E; Tazi K A; Chauvelot-Moachon L; Guimont M C; Bories P N; Poirel O; Moreau R; Lebrec D
Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis.
Journal of hepatology 2000;33(3):376-81.
2000: Lebrec D
Pretransplantation gastrointestinal bleeding.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2000;6(4 Suppl 1):S57-62.
2000: Chagneau C; Tazi K A; Heller J; Sogni P; Poirel O; Moreau R; Lebrec D
The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertension.
Journal of hepatology 2000;33(1):26-32.
2000: Tazi K A; Moreau R; Heller J; Poirel O; Lebrec D
Changes in protein kinase C isoforms in association with vascular hyporeactivity in cirrhotic rat aortas.
Gastroenterology 2000;119(1):201-10.
2000: Pateron D; Tazi K A; Sogni P; Heller J; Chagneau C; Poirel O; Philippe M; Moreau R; Lebrec D
Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension.
Gastroenterology 2000;119(1):196-200.
2000: Moreau R; Tazi K A; Komeichi H; Pussard E; Lebrec D
Haemodynamic responses to a ring-deleted analogue of atrial natriuretic peptide in rats with cirrhosis.
Liver 2000;20(1):88-92.
2000: Gadano A; Moreau R; Pessione F; Trombino C; Giuily N; Sinnassamy P; Valla D; Lebrec D
Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis.
Journal of hepatology 2000;32(1):38-42.
1999: Pateron D; Oberti F; Lefilliatre P; Veal N; Tazi K A; Sogni P; Poirel O; Heller J; Moreau R; Cales P; Lebrec D
Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis.
Clinical science (London, England : 1979) 1999;97(3):313-8.
1999: Heller J; Sogni P; Tazi K A; Chagneau C; Poirel O; Moreau R; Lebrec D
Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration.
Hepatology (Baltimore, Md.) 1999;30(3):698-704.
1999: Gadano A; Moreau R; Heller J; Chagneau C; Vachiéry F; Trombino C; Elman A; Denié C; Valla D; Lebrec D
Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis.
Gut 1999;45(1):117-21.
1999: Lebrec D; Moreau R
Pathophysiology of portal hypertension.
Hepato-gastroenterology 1999;46 Suppl 2():1426-8.
1999: Gadano A C; Sogni P; Heller J; Moreau R; Bories P N; Lebrec D
Vascular nitric oxide production during the development of two experimental models of portal hypertension.
Journal of hepatology 1999;30(5):896-903.
1999: Moreau R; Lebrec D
[Management of patients with cirrhosis and ascites]
Gastroentérologie clinique et biologique 1999;23(3):379-87.
1999: Pateron D; Beyne P; Laperche T; Logeard D; Lefilliatre P; Sogni P; Moreau R; Langlet P; Elman A; Bernuau J; Valla D; Erlinger S; Lebrec D
Elevated circulating cardiac troponin I in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1999;29(3):640-3.
1999: Lahaye P; Fouassier L; Tazi K A; De Gottardi A; Fléjou J F; Chagneau C; Rona J P; Housset C; Reichen J; Lebrec D; Moreau R
Endothelium-dependent blunted membrane potential responses to ATP-sensitive K+ channel modulators in aortae from rats with cirrhosis.
Journal of hepatology 1999;30(1):107-14.
1999: Sauvanet A; Yang S; Bernuau D; Beyne P; Denninger M H; Farges O; Lebrec D; Belghiti J
Auxiliary liver transplantation: how to improve regeneration of the native liver by surgery.
Transplant international : official journal of the European Society for Organ Transplantation 1999;12(6):433-8.
1998: Kirstetter P; Lagneau F; Le Corre F; Cailmail S; Moreau R; Lebrec D; Marty J
Vascular properties of isoflurane: comparison between normal and cirrhotic rats.
British journal of anaesthesia 1998;81(6):968-9.
1998: Moreau R; Oberti F; Lahaye P; Gadano A; Cailmail S; Sogni P; Cales P; Lebrec D
In vitro and in vivo vascular responses to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis.
Journal of gastroenterology and hepatology 1998;13(12):1254-8.
1998: Hadengue A; Gadano A; Moreau R; Giostra E; Durand F; Valla D; Erlinger S; Lebrec D
Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome.
Journal of hepatology 1998;29(4):565-70.
1998: Lahaye P; Tazi K A; Rona J P; Dellis O; Lebrec D; Moreau R
Effects of protein kinase C modulators on Na+/K+ adenosine triphosphatase activity and phosphorylation in aortae from rats with cirrhosis.
Hepatology (Baltimore, Md.) 1998;28(3):663-9.
1998: Sogni P; Moreau R; Gomola A; Gadano A; Cailmail S; Calmus Y; Clozel M; Lebrec D
Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats.
Hepatology (Baltimore, Md.) 1998;28(3):655-9.
1998: Denié C; Vachiéry F; Gadano A; Sogni P; Elman A; Moreau R; Valla D; Lebrec D
Influence of transjugular intrahepatic portosystemic shunts (TIPS) on tissue oxygenation in patients with cirrhosis.
Liver 1998;18(4):239-44.
1998: Lebrec D
A discussion of how terlipressin limits mortality in cases of bleeding oesophageal varices.
European journal of gastroenterology & hepatology 1998;10(7):549-52.
1998: Lebrec D
Medical decompressive therapy for prophylaxis of rebleeding.
Digestion 1998;59 Suppl 2():48-9.
1998: Moreau R; Lebrec D
Transduction of antinatriuretic signals in renal proximal tubular cells in cirrhosis: introduction to novel approaches to the treatment of sodium retention.
Journal of hepatology 1998;28(6):1064-9.
1998: Lebrec D
Pharmacological treatment of portal hypertension: present and future.
Journal of hepatology 1998;28(5):896-907.
1998: Trombino C; Tazi K A; Gadano A; Moreau R; Lebrec D
Protein kinase C alterations in aortic vascular smooth muscle cells from rats with cirrhosis.
Journal of hepatology 1998;28(4):670-6.
1998: Sogni P; Yang S; Pilette C; Moreau R; Gadano A; Avenard G; Bloy C; Lebrec D
Acute and chronic haemodynamic effects of naftazone in portal hypertensive rats.
European journal of pharmacology 1998;344(1):37-43.
1997: Tazi K A; Trombino C; Moreau R; Lebrec D
Responsiveness to growth factors in aortic vascular smooth muscle cells from rats with cirrhosis.
The American journal of physiology 1997;273(4 Pt 1):G883-90.
1997: Gadano A; Durand F; Degott C; Dosquet C; Moreau R; Hadengue A; Widmann J J; Vachiery F; Elman A; Sogni P; Yang S; Valla D; Bernuau J; Belghiti J; Erlinger S; Lebrec D
Studies of portal hemodynamics and hepatic oxygen consumption during acute liver allograft rejection.
Transplantation 1997;64(8):1188-92.
1997: Moreau R; Cailmail S; Valla D; Lebrec D
Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
Alimentary pharmacology & therapeutics 1997;11(5):993-7.
1997: Vachiéry F; Moreau R; Hadengue A; Gadano A; Soupison T; Valla D; Lebrec D
Hypoxemia in patients with cirrhosis: relationship with liver failure and hemodynamic alterations.
Journal of hepatology 1997;27(3):492-5.
1997: Moreau R; Cailmail S; Gadano A; Valla D; Lebrec D
Haemodynamic effects of octreotide in portal hypertensive rats receiving propranolol.
Alimentary pharmacology & therapeutics 1997;11(4):775-9.
1997: Le Moine O; Hadengue A; Moreau R; Sogni P; Soupison T; Yang S; Hartleb M; Lebrec D
Relationship between portal pressure, esophageal varices, and variceal bleeding on the basis of the stage and cause of cirrhosis.
Scandinavian journal of gastroenterology 1997;32(7):731-5.
1997: Gadano A; Moreau R; Vachiery F; Soupison T; Yang S; Cailmail S; Sogni P; Hadengue A; Durand F; Valla D; Lebrec D
Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.
Journal of hepatology 1997;26(6):1229-34.
1997: Tazi K A; Moreau R; Cailmail S; Gadano A; Trombino C; Lebrec D
Altered growth and lack of responsiveness to angiotensin II in aortic vascular smooth muscle cells from cirrhotic rats.
Gastroenterology 1997;112(6):2065-72.
1997: Lebrec D
Recent situation in drug treatment for esophageal varices.
Hepato-gastroenterology 1997;44(15):615-9.
1997: Sogni P; Smith A P; Gadano A; Lebrec D; Higenbottam T W
Induction of nitric oxide synthase II does not account for excess vascular nitric oxide production in experimental cirrhosis.
Journal of hepatology 1997;26(5):1120-7.
1997: Kirstetter P; Moreau R; Vachiery F; Gadano A; Soupison T; Pilette C; Pussard E; Cailmail S; Takahashi H; Lebrec D
Plasma concentrations of cyclic 3', 5'-guanosine monophosphate in patients with cirrhosis: relationship with atrial natriuretic peptide and haemodynamics.
Journal of gastroenterology and hepatology 1997;12(3):233-6.
1997: Gadano A C; Sogni P; Yang S; Cailmail S; Moreau R; Nepveux P; Couturier D; Lebrec D
Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats.
Journal of hepatology 1997;26(3):678-86.
1997: Sogni P; Hadengue A; Moreau R; Le Moine O; Soupison T; Oberti F; Farinotti R; Lebrec D
Acute effects of propylthiouracil on hemodynamics and oxygen content in patients with alcoholic cirrhosis.
Journal of hepatology 1997;26(3):628-33.
1997: Gadano A; Hadengue A; Vachiery F; Moreau R; Sogni P; Soupison T; Yang S; Cailmail S; Lebrec D
Relationship between hepatic blood flow, liver tests, haemodynamic values and clinical characteristics in patients with chronic liver disease.
Journal of gastroenterology and hepatology 1997;12(2):167-71.
1997: Lebrec D
Review: pharmacotherapeutic agents in the treatment of portal hypertension.
Journal of gastroenterology and hepatology 1997;12(2):159-66.
1997: Safka V; Moreau R; Gadano A; Lebrec D
Vascular hyporesponsiveness to vasodilators in rats with cirrhosis.
Journal of hepatology 1997;26(2):382-6.
1997: Lebrec D
[Primary prevention of digestive hemorrhage in portal hypertension]
Gastroentérologie clinique et biologique 1997;21(5):391-3.
1997: Denié C; Poynard T; Gadano A; Vachiery F; Soupison T; Elman A; Valla D; Moreau R; Lebrec D
[Influence of anemia on hemodynamic changes in patients with cirrhosis]
Gastroentérologie clinique et biologique 1997;21(1):29-33.
1996: D'Almeida M S; Cailmail S; Lebrec D
Validation of transit-time ultrasound flow probes to directly measure portal blood flow in conscious rats.
The American journal of physiology 1996;271(6 Pt 2):H2701-9.
1996: Denié C; Vachiery F; Elman A; Soupison T; Gadano A; Moreau R; Lebrec D
Systemic and splanchnic hemodynamic changes in patients with hepatic schistosomiasis.
Liver 1996;16(5):309-12.
1996: Pilette C; Moreau R; Sogni P; Kirstetter P; Cailmail S; Pussard E; Lebrec D
Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension.
European journal of pharmacology 1996;312(1):63-8.
1996: Moreau R; Cailmail S; Hamon G; Lebrec D
Renal and haemodynamic responses to a novel kappa opioid receptor agonist, niravoline (RU 51,599), in rats with cirrhosis.
Journal of gastroenterology and hepatology 1996;11(9):857-63.
1996: Vachiery F; Moreau R; Gadano A; Yang S; Sogni P; Hadengue A; Cailmail S; Soupison T; Lebrec D
Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker.
Digestive diseases and sciences 1996;41(9):1722-6.
1996: Lebrec D; Giuily N; Hadengue A; Vilgrain V; Moreau R; Poynard T; Gadano A; Lassen C; Benhamou J P; Erlinger S
Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.
Journal of hepatology 1996;25(2):135-44.
1996: Kirstetter P; Moreau R; Soupison T; Cailmail S; Hartleb M; Lebrec D
Role of sympathetic cardiovascular tone in control of arterial pressure in rats with cirrhosis.
Liver 1996;16(4):263-6.
1996: Soupison T; Yang S; Bernard C; Moreau R; Kirstetter P; D'Almeida M; Cailmail S; Tedgui A; Lebrec D
Acute haemodynamic responses and inhibition of tumour necrosis factor-alpha by pentoxifylline in rats with cirrhosis.
Clinical science (London, England : 1979) 1996;91(1):29-33.
1996: Sogni P; Sabry S; Moreau R; Gadano A; Lebrec D; Dinh-Xuan A T
Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats.
Journal of hepatology 1996;24(4):487-90.
1996: Kirstetter P; Pilette C; Moreau R; Cailmail S; Safka V; Soupison T; Lebrec D
Role of pentobarbitone anaesthesia and sympathetic tone in the haemodynamic effects of isosorbide dinitrate in rats with cirrhosis.
Journal of gastroenterology and hepatology 1996;11(3):230-5.
1996: Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D
Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats.
Journal of gastroenterology and hepatology 1996;11(1):1-6.
1996: Lebrec D
Various approaches to obtaining liver tissue--choosing the biopsy technique.
Journal of hepatology 1996;25 Suppl 1():20-4.
1995: Sogni P; Garnier P; Gadano A; Moreau R; Dall'Ava-Santucci J; Dinh-Xuan A T; Lebrec D
Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis.
Journal of hepatology 1995;23(4):471-3.
1995: Le Moine O; Soupison T; Sogni P; Marchant A; Moreau R; Hadengue A; Goldman M; Devière J; Lebrec D
Plasma endotoxin and tumor necrosis factor-alpha in the hyperkinetic state of cirrhosis.
Journal of hepatology 1995;23(4):391-5.
1995: Gaudin C; Moreau R; Champigneulle B; Soubrane O; Kleber G; Lebrec D
Short-term cardiovascular effects of somatostatin in patients with cirrhosis.
Liver 1995;15(5):236-41.
1995: Yang S; Soubrane O; Cailmail S; Gaudin C; Moreau R; Belghiti J; Lebrec D
Effects of superior mesenteric artery stenosis on splanchnic and systemic hemodynamics in conscious rats with biliary cirrhosis.
Journal of hepatology 1995;22(4):481-5.
1995: D'Almeida M S; Gaudin C; Lebrec D
Validation of 1- and 2-mm transit-time ultrasound flow probes on mesenteric artery and aorta of rats.
The American journal of physiology 1995;268(3 Pt 2):H1368-72.
1995: Moreau R; Lebrec D
Endogenous factors involved in the control of arterial tone in cirrhosis.
Journal of hepatology 1995;22(3):370-6.
1995: Komeichi H; Moreau R; Cailmail S; Gaudin C; Lebrec D
Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis.
Journal of hepatology 1995;22(3):319-25.
1995: Hartleb M; Moreau R; Gaudin C; Lebrec D
Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis.
Journal of hepatology 1995;22(2):202-7.
1994: Komeichi H; Moreau R; Cailmail S; Gaudin C; Lebrec D
Hemodynamic responses to selective blockade of beta 2- and beta 1-adrenoceptors in conscious rats with cirrhosis.
Journal of hepatology 1994;21(5):779-86.
1994: Hartleb M; Moreau R; Cailmail S; Gaudin C; Lebrec D
Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis.
Gastroenterology 1994;107(4):1085-93.
1994: Moreau R; Komeichi H; Kirstetter P; Yang S; Aupetit-Faisant B; Cailmail S; Lebrec D
Effects of glibenclamide on systemic and splanchnic haemodynamics in conscious rats.
British journal of pharmacology 1994;112(2):649-53.
1994: Moreau R; Komeichi H; Kirstetter P; Ohsuga M; Cailmail S; Lebrec D
Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis.
Gastroenterology 1994;106(4):1016-23.
1994: Sogni P; Soupison T; Moreau R; Le Moine O; Bacq Y; Hadengue A; Lebrec D
Hemodynamic effects of acute administration of furosemide in patients with cirrhosis receiving beta-adrenergic antagonists.
Journal of hepatology 1994;20(4):548-52.
1994: Lebrec D
Long-term management of variceal bleeding: the place of pharmacotherapy.
World journal of surgery 1994;18(2):229-32.
1994: Ohsuga M; Moreau R; Hartleb M; Komeichi H; Lebrec D
Blunted systemic, splanchnic, and renal hemodynamic responses to atrial natriuretic peptide in rats with cirrhosis.
Journal of hepatology 1994;20(1):91-6.
1994: Lebrec D
Pharmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding.
Pharmacology & therapeutics 1994;61(1-2):65-107.
1994: Moreau R; Lebrec D
[Effects of atrial natriuretic factor on renal excretion of sodium in patients with liver cirrhosis]
Gastroentérologie clinique et biologique 1994;18(6-7):568-73.
1994: Hartleb M; Kirstetter P; Moreau R; Soupison T; Pussard E; Hadengue A; Sogni P; Gaudin C; Lebrec D
[Relationships between plasma concentrations of endothelin and the severity of liver cirrhosis]
Gastroentérologie clinique et biologique 1994;18(5):407-12.
1993: Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
Hepatology (Baltimore, Md.) 1993;18(3):621-7.
1993: Hadengue A; Lebrec D; Moreau R; Sogni P; Durand F; Gaudin C; Bernuau J; Belghiti J; Gayet B; Erlinger S
Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients.
Hepatology (Baltimore, Md.) 1993;17(2):175-8.
1993: Ohsuga M; Cailmail S; Lebrec D
Hemodynamic effects of nipradilol, a new beta-adrenergic antagonist combined with a nitroxy base, in rats with intra- or extra-hepatic portal hypertension.
Journal of hepatology 1993;17(2):236-40.
1993: Braillon A; Cailmail S; Gaudin C; Lebrec D
Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis.
Journal of hepatology 1993;17(1):86-90.
1993: Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Journal of hepatology 1993;17(1):102-7.
1993: Moreau R; Gaudin C; Hadengue A; Braillon A; Roulot D; Bacq Y; Lebrec D
Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure.
Nephron 1993;65(3):359-63.
1993: Lebrec D
Pharmacologic prevention of variceal bleeding and rebleeding.
Journal of hepatology 1993;17 Suppl 2():S29-33.
1992: Soubrane O; Braillon A; Lin H C; Kleber G; Lebrec D
Hemodynamic effects of calibrated stenosis of the superior mesenteric artery in conscious rats with portal vein stenosis.
Hepatology (Baltimore, Md.) 1992;16(6):1447-51.
1992: Sogni P; Moreau R; Ohsuga M; Cailmail S; Oberti F; Hadengue A; Pussard E; Lebrec D
Evidence for normal nitric oxide-mediated vasodilator tone in conscious rats with cirrhosis.
Hepatology (Baltimore, Md.) 1992;16(4):980-3.
1992: Moreau R; Komeichi H; Cailmail S; Lebrec D
Blockade of ATP-sensitive K+ channels by glibenclamide reduces portal pressure and hyperkinetic circulation in portal hypertensive rats.
Journal of hepatology 1992;16(1-2):215-8.
1992: Koshy A; Sekiyama T; Hadengue A; Cerini R; Braillon A; Lebrec D
Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertension.
Journal of gastroenterology and hepatology 1992;7(5):449-54.
1992: Moreau R; Soubrane O; Sogni P; Hadengue A; Gaudin C; Lin H C; Pussard E; Nahoul K; Lebrec D
Hemodynamic, neurohumoral, and metabolic responses to amino acid infusion in patients with cirrhosis.
Gastroenterology 1992;103(2):601-8.
1992: Kleber G; Braillon A; Gaudin C; Champigneulle B; Cailmail S; Lebrec D
Hemodynamic effects of endotoxin and platelet activating factor in cirrhotic rats.
Gastroenterology 1992;103(1):282-8.
1992: Moreau R; Champigneulle B; Gaudin C; Poo J L; Kleber G; Bacq Y; Lebrec D
Effects of theophylline on hemodynamics and tissue oxygenation in patients with cirrhosis.
Journal of hepatology 1992;15(3):323-9.
1992: Hadengue A; Moreau R; Gaudin C; Bacq Y; Champigneulle B; Lebrec D
Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion.
Hepatology (Baltimore, Md.) 1992;15(5):809-15.
1992: Poo J L; Feldmann G; Erlinger S; Braillon A; Gaudin C; Dumont M; Lebrec D
Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.
Gastroenterology 1992;102(5):1752-9.
1992: Roulot D; Moreau R; Gaudin C; Bacq Y; Braillon A; Hadengue A; Frohly P; Lebrec D
Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites.
Gastroenterology 1992;102(4 Pt 1):1309-18.
1992: Lebrec D
Methods to evaluate portal hypertension.
Gastroenterology clinics of North America 1992;21(1):41-59.
1992: Brenard R; Moreau R; Pussard E; Champigneulle B; Gaudin C; Hadengue A; Braillon A; Lebrec D
Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis.
Journal of hepatology 1992;14(2-3):347-56.
1992: Poo J L; Braillon A; Hadengue A; Gaudin C; Lebrec D
Hemodynamic effects of terbutaline, a beta 2-adrenoceptor agonist, in conscious rats with secondary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1992;15(3):459-63.
1992: Abergel A; Braillon A; Gaudin C; Kleber G; Lebrec D
Persistence of a hyperdynamic circulation in cirrhotic rats following removal of the sympathetic nervous system.
Gastroenterology 1992;102(2):656-60.
1992: Braillon A; Gaudin C; Poo J L; Moreau R; Debaene B; Lebrec D
Plasma catecholamine concentrations are a reliable index of sympathetic vascular tone in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1992;15(1):58-62.
1992: Gaudin C; Braillon A; Moreau R; Roulot D; Hadengue A; Lebrec D
[Renal sympathetic nervous activity in patients with cirrhosis]
Gastroentérologie clinique et biologique 1992;16(6-7):498-503.
1992: Debaene B; Goldfarb G; Braillon A; Lebrec D
[Effects of halogenated anesthetics on splanchnic hemodynamic in normo- and hypovolemic cirrhotic rats]
Annales françaises d'anesthèsie et de rèanimation 1992;11(1):35-42.
1992: Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
[Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis]
Gastroentérologie clinique et biologique 1992;16(8-9):680-6.
1992: Moreau R; Hadengue A; Gaudin C; Sogni P; Soubrane O; Lebrec D
[Effect of the severity of liver disease on renal hemodynamics and renal oxygen consumption in patients with cirrhosis]
Gastroentérologie clinique et biologique 1992;16(4):309-13.
1991: Moreau R; Hadengue A; Pussard E; Soubrane O; Sogni P; Gaudin C; Lebrec D
Relationships between plasma atrial natriuretic peptide concentrations and hemodynamics and hematocrit in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1991;14(6):1035-9.
1991: Moreau R; Pussard E; Brenard R; Gaudin C; Berdeaux A; Lebrec D
Clearance of atrial natriuretic peptide in patients with cirrhosis. Role of liver failure.
Journal of hepatology 1991;13(3):351-7.
1991: Bacq Y; Gaudin C; Hadengue A; Roulot D; Braillon A; Moreau R; Lebrec D
Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1991;14(3):483-7.
1991: Lin H C; Soubrane O; Cailmail S; Lebrec D
Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats.
Journal of hepatology 1991;13(2):213-9.
1991: Gaudin C; Braillon A; Poo J L; Moreau R; Hadengue A; Lebrec D
Regional sympathetic activity, severity of liver disease and hemodynamics in patients with cirrhosis.
Journal of hepatology 1991;13(2):161-8.
1991: Lin H C; Soubrane O; Lebrec D
Prevention of portal hypertension and portosystemic shunts by early chronic administration of clonidine in conscious portal vein-stenosed rats.
Hepatology (Baltimore, Md.) 1991;14(2):325-30.
1991: Gaudin C; Braillon A; Poo J L; Kleber G; Moreau R; Lebrec D
Plasma catecholamines in patients with presinusoidal portal hypertension: comparison with cirrhotic patients and nonportal hypertensive subjects.
Hepatology (Baltimore, Md.) 1991;13(5):913-6.
1991: Champigneulle B; Braillon A; Kleber G; Gaudin C; Cailmail S; Lebrec D
Adenosine and hemodynamic alterations in cirrhotic rats.
The American journal of physiology 1991;260(4 Pt 1):G543-7.
1991: Lebrec D
[Medical treatment of portal hypertension]
Presse médicale (Paris, France : 1983) 1991;20(16):750-5.
1991: Lee S S; Hadengue A; Girod C; Braillon A; Lebrec D
Divergent circulatory effects of betaxolol in conscious and anesthetized normal and portal hypertensive rats.
Journal of hepatology 1991;12(2):157-61.
1991: Gaudin C; Braillon A; Kleber G; Girod C; Lebrec D
Variability of hemodynamic values and plasma catecholamine concentrations over a one-hour period in conscious, restrained rats.
Journal of pharmacological methods 1991;25(1):1-9.
1991: Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
Hepatology (Baltimore, Md.) 1991;13(1):111-6.
1991: Lebrec D
[Beta-adrenergic antagonists and endoscopic sclerotherapy for the prevention of digestive hemorrhage]
Gastroentérologie clinique et biologique 1991;15(11):829-32.
1990: Lebrec D
Beta-blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding.
Hepato-gastroenterology 1990;37(6):556-60.
1990: Goldfarb G; Debaene B; Ang E T; Roulot D; Jolis P; Lebrec D
Hepatic blood flow in humans during isoflurane-N2O and halothane-N2O anesthesia.
Anesthesia and analgesia 1990;71(4):349-53.
1990: Bacq Y; Roulot D; Braillon A; Lebrec D
Hemodynamic effects of dopamine in conscious rats with secondary biliary cirrhosis.
Journal of hepatology 1990;11(2):257-62.
1990: Lee S S; Marty J; Mantz J; Samain E; Braillon A; Lebrec D
Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats.
Hepatology (Baltimore, Md.) 1990;12(3 Pt 1):481-5.
1990: Lebrec D; Hadengue A; Gaudin C; Levron J C; Fraitag B; Berthelot P; Benhamou J P
Pharmacokinetics of ketanserin in patients with cirrhosis.
Clinical pharmacokinetics 1990;19(2):160-6.
1990: Debaene B; Goldfarb G; Braillon A; Jolis P; Lebrec D
Effects of ketamine, halothane, enflurane, and isoflurane on systemic and splanchnic hemodynamics in normovolemic and hypovolemic cirrhotic rats.
Anesthesiology 1990;73(1):118-24.
1990: Lebrec D
Current status and future goals of the pharmacologic reduction of portal hypertension.
American journal of surgery 1990;160(1):19-25.
1990: Gaudin C; Braillon A; Selz F; Cuche J L; Lebrec D
Free and conjugated catecholamines in patients with cirrhosis.
The Journal of laboratory and clinical medicine 1990;115(5):589-92.
1990: Chaland P; Braillon A; Gaudin C; Sekiyama T; Bernuau D; Adam R; Bismuth H; Benhamou J P; Lebrec D
Orthotopic liver transplantation with hepatic artery anastomoses. Hemodynamics and response to hemorrhage in conscious rats.
Transplantation 1990;49(4):675-8.
1990: Koshy A; Sekiyama T; Cereda J M; Hadengue A; Girod C; Lebrec D
Effects of haemorrhage and volume expansion on portal-systemic collateral vascular resistance in conscious portal hypertensive rats.
Clinical science (London, England : 1979) 1990;78(2):193-7.
1990: Lebrec D
Portal hypertension: serotonin and pathogenesis.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1990;4 Suppl 1():33-5.
1990: Johansen K; Girod C; Lee S S; Lebrec D
Mesenteric venous stenosis reduces hyperammonemia in the portacaval-shunted rat.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 1990;22(3):170-4.
1989: Moreau R; Braillon A; Roulot D; Hadengue A; Gaudin C; Cereda J M; Sicot C; Lebrec D
[Tissue hypoxia and hepatocellular insufficiency in patients with cirrhosis]
Gastroentérologie clinique et biologique 1989;13(12):978-83.
1989: Braillon A; Moreau R; Hadengue A; Roulot D; Sayegh R; Lebrec D
Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol.
Journal of hepatology 1989;9(3):312-8.
1989: Roulot D; Braillon A; Gaudin C; Ozier Y; Girod C; Lebrec D
Mechanisms of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats.
Hepatology (Baltimore, Md.) 1989;10(4):477-81.
1989: Ozier Y; Braillon A; Gaudin C; Roulot D; Hadengue A; Lebrec D
Hepatic denervation alters hemodynamic response to hemorrhage in conscious rats.
Hepatology (Baltimore, Md.) 1989;10(4):473-6.
1989: Roulot D; Gaudin C; Braillon A; Sekiyama T; Bacq Y; Lebrec D
Hemodynamic effects of a combination of clonidine and propranolol in conscious cirrhotic rats.
Canadian journal of physiology and pharmacology 1989;67(10):1369-72.
1989: Lebrec D
[Idiopathic portal hypertension]
Gastroentérologie clinique et biologique 1989;13(10):761-2.
1989: Cereda J M; Roulot D; Braillon A; Moreau R; Koshy A; Lebrec D
Reduction of portal pressure by acute administration of furosemide in patients with alcoholic cirrhosis.
Journal of hepatology 1989;9(2):246-51.
1989: Koshy A; Moreau R; Cerini R; Roulot D; Bacq Y; Hadengue A; Lebrec D
Effects of oxygen inhalation on tissue oxygenation in patients with cirrhosis. Evidence for an impaired arterial baroreflex control.
Journal of hepatology 1989;9(2):240-5.
1989: Gaudin C; Braillon A; Moreau R; Roulot D; Bacq Y; Hadengue A; Lebrec D
[Relation between plasma catecholamines, the severity of the liver disease and hemodynamics in patients with cirrhosis]
Gastroentérologie clinique et biologique 1989;13(8-9):701-6.
1989: Cerini R; Braillon A; Hadengue A; Koshy A; Lee S S; Lebrec D
Somatostatin analogue improves survival in conscious cirrhotic rats subjected to gastrointestinal bleeding.
Clinical science (London, England : 1979) 1989;77(1):7-9.
1989: Cerini R; Koshy A; Hadengue A; Lee S S; Garnier P; Lebrec D
Effects of glucagon on systemic and splanchnic circulation in conscious rats with biliary cirrhosis.
Journal of hepatology 1989;9(1):69-74.
1989: Moreau R; Roulot D; Braillon A; Gaudin C; Hadengue A; Bacq Y; Lebrec D
Low dose of nitroglycerin failed to improve splanchnic hemodynamics in patients with cirrhosis: evidence for an impaired cardiopulmonary baroreflex function.
Hepatology (Baltimore, Md.) 1989;10(1):93-7.
1989: Cereda J M; Braillon A; Ozier Y; Moreau R; Gaudin C; Lebrec D
[Influence of ascites on splanchnic and systemic hemodynamics in patients with alcoholic cirrhosis]
Gastroentérologie clinique et biologique 1989;13(5):495-8.
1989: Moreau R; Lee S S; Hadengue A; Ozier Y; Sicot C; Lebrec D
Relationship between oxygen transport and oxygen uptake in patients with cirrhosis: effects of vasoactive drugs.
Hepatology (Baltimore, Md.) 1989;9(3):427-32.
1989: Koshy A; Girod C; Lee S S; Hadengue A; Cerini R; Lebrec D
Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats.
Hepatology (Baltimore, Md.) 1989;9(2):269-73.
1989: Hadengue A; Moreau R; Cerini R; Koshy A; Lee S S; Lebrec D
Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect.
Hepatology (Baltimore, Md.) 1989;9(1):83-7.
1989: Gaudin C; Ruget G; Braillon A; Selz F; Cuche J L; Lebrec D
Portal and arterial free and conjugated noradrenaline in two models of portal hypertension in rats.
Life sciences 1989;45(15):1333-9.
1989: Goldfarb G; Debaene B; Ang E T; Jolis P; Lebrec D
[Comparative effects of isoflurane and halothane on hepatic blood circulation in man]
Annales françaises d'anesthèsie et de rèanimation 1989;8 Suppl():R138.
1989: Ozier Y; Braillon A; Gaudin C; Roulot D; Hadengue A; Lebrec D
[Liver denervation aggravates the hemodynamic response to hemorrhage in the conscious rat]
Annales françaises d'anesthèsie et de rèanimation 1989;8 Suppl():R111.
1989: Debaene B; Goldfarb G; Braillon A; Jolis P; Lebrec D
[Splanchnic hemodynamic changes caused by ketamine and propofol in the cirrhotic rat. Effects of hemorrhage]
Annales françaises d'anesthèsie et de rèanimation 1989;8 Suppl():R110.
1988: Koshy A; Cerini R; Bernuau D; Hadengue A; Girod C; Lebrec D
Model for the study of portal-systemic collateral vascular resistance in the conscious rat.
Journal of pharmacological methods 1988;20(3):265-77.
1988: Lee S S; Moreau R; Hadengue A; Cerini R; Koshy A; Lebrec D
Glucagon selectively increases splanchnic blood flow in patients with well-compensated cirrhosis.
Hepatology (Baltimore, Md.) 1988;8(6):1501-5.
1988: Braillon A; Koshy A; Lee S S; Girod C; Lebrec D
[Effect of the development of portosystemic shunts in the maintenance of portal hypertension in rats]
Gastroentérologie clinique et biologique 1988;12(8-9):641-5.
1988: Lebrec D; Poynard T; Capron J P; Hillon P; Geoffroy P; Roulot D; Chaput J C; Rueff B; Benhamou J P
Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial.
Journal of hepatology 1988;7(1):118-25.
1988: Pugliese D; Lee S S; Koshy A; Cerini R; Ozier Y; Lebrec D
Systemic and splanchnic hemodynamic effects of intravenous hypertonic glucose in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1988;8(3):643-6.
1988: Lee S S; Hadengue A; Moreau R; Sayegh R; Hillon P; Lebrec D
Postprandial hemodynamic responses in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1988;8(3):647-51.
1988: Hadengue A; Lee S S; Koshy A; Girod C; Lebrec D
Regional blood flows by the microsphere method: reproducibility in portal hypertensive rats and influence of a portal vein catheter.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1988;187(4):461-8.
1988: Hadengue A; Moreau R; Lee S S; Gaudin C; Rueff B; Lebrec D
Liver hypermetabolism during alcohol withdrawal in humans. Role of sympathetic overactivity.
Gastroenterology 1988;94(4):1047-52.
1988: Jiron M I; Lee S S; Cerini R; Pugliese D; Hadengue A; Lebrec D
Effects of nitroglycerin on forearm haemodynamics in patients with cirrhosis.
Clinical science (London, England : 1979) 1988;74(4):433-6.
1988: Cerini R; Lee S S; Hadengue A; Koshy A; Girod C; Lebrec D
Circulatory effects of somatostatin analogue in two conscious rat models of portal hypertension.
Gastroenterology 1988;94(3):703-8.
1988: Valla D; Girod C; Lee S S; Braillon A; Lebrec D
Lack of vasopressin action on splanchnic hemodynamics during bleeding: a study in conscious, portal hypertensive rats.
Hepatology (Baltimore, Md.) 1988;8(1):10-5.
1988: Lebrec D
The medical prevention of variceal bleeding.
Intensive care medicine 1988;14(2):97-9.
1987: Lee S S; Hadengue A; Moreau R; Girod C; Jiron M I; Lebrec D
Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and rats.
Journal of hepatology 1987;5(2):149-53.
1987: Valla D; Jiron M I; Poynard T; Braillon A; Lebrec D
Failure of haemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol.
Journal of hepatology 1987;5(2):144-8.
1987: Hadengue A; Lee S S; Moreau R; Lebrec D
Oxygen and bile acid content in the azygos blood. Clues to the azygos derivation in patients with portal hypertension.
Journal of hepatology 1987;5(1):98-101.
1987: Goldfarb G; Lebrec D
[Effects of anesthetic agents on hepatic blood flow]
Annales françaises d'anesthèsie et de rèanimation 1987;6(6):498-506.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Didier Lebrec

Research Profile (preview)

Physiology

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Didier Lebrec (preview)

All Publications